EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis

Jian-Chao Wang iD, Yun Peng, Bing Dai, Hai-Jia Hou, Hong-Wen Zhao, Wei Wang, Wei Tan iD

Therapeutic Advances in Respiratory Disease · 2024-01 · 18

DOI: 10.1177/17534666231225323 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 17.01.2024. Verfasst von Jian-Chao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: COVID-19, Noninvasive Ventilation, Respiratory Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Science and Technology of Liaoning Province, Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-flow nasal cannula (HFNC) and conventional oxygen therapy (COT) are important respiratory support strategies for acute hypoxemic respiratory failure (AHRF) in coronavirus disease 2019 (COVID-19) patients. However, the results are conflicting for the risk of intubation with HFNC as compared to COT.

Objectives

We systematically synthesized the outcomes of HFNC relative to COT in COVID-19 patients with AHRF and evaluated these outcomes in relevant subpopulations.

Design

This study was designed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources and methods: We searched PubMed, EMBASE, Web of Science, Scopus, ClinicalTrials.gov, medRxiv, BioRxiv, and the Cochrane Central Register of Controlled Trials for randomized controlled trials and observational studies that compared the efficacy of HFNC with COT in patients with COVID-19-related AHRF. Primary outcomes were intubation rate and mortality rate. Secondary outcomes were the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO 2 /FiO 2 ), respiratory rate, hospital length of stay, intensive care unit (ICU) length of stay, and days free from invasive mechanical ventilation.

Results

In total, 20 studies with 5732 patients were included. We found a decreased risk of requiring intubation in HFNC compared to COT [odds ratio (OR) = 0.61, 95% confidence interval (CI): 0.46–0.82, p = 0.0009, I 2 = 75%]. Similarly, we found HFNC was associated with lower risk of intubation rate compared to COT in the subgroup of patients with baseline PaO 2 /FiO 2 < 200 mmHg (OR = 0.69, 95% CI: 0.55–0.86, p = 0.0007, I 2 = 45%), and who were in ICU settings at enrollment (OR = 0.57, 95% CI: 0.38–0.85, p = 0.005, I 2 = 80%). HFNC was associated with an improvement of PaO 2 /FiO 2 and respiratory rate compared to COT. The use of HFNC compared to COT did not reduce the mortality rate, days free from invasive mechanical ventilation, hospital length of stay, or ICU length of stay.

Conclusion

Compared to COT, HFNC may decrease the need for tracheal intubation in patients with COVID-19-related AHRF, particularly among patients with baseline PaO 2 /FiO 2 < 200 mmHg and those in ICU settings.

Trial registration

This systematic review and meta-analysis protocol was prospectively registered with PROSPERO (no. CRD42022339072).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Noninvasive VentilationRespiratory InsufficiencyHumansCannulaOxygenOxygen Inhalation Therapy

Stichwörter der Autor:innen

COVID-19conventional oxygen therapyhigh-flow nasal cannula

Substanzen

Oxygen

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
  • Department of Intensive Care Medicine, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Heping District, Shenyang, China.
  • Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang 110001, China.

ORCID-Profile: Jian-Chao Wang, Wei Tan

Förderung

  • Department of Science and Technology of Liaoning Province
  • Science and Technology Planning Project

Zitieren

APA

Wang, J. C., Peng, Y., Dai, B., Hou, H. J., Zhao, H. W., Wang, W., & Tan, W. (2024). Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666231225323

Vancouver

Wang JC, Peng Y, Dai B, Hou HJ, Zhao HW, Wang W, et al. Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666231225323

BibTeX
@article{Wang2024,
  author = {Wang, Jian-Chao and Peng, Yun and Dai, Bing and Hou, Hai-Jia and Zhao, Hong-Wen and Wang, Wei and Tan, Wei},
  title = {Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2024},
  volume = {18},
  doi = {10.1177/17534666231225323}
}
Kostenlos starten →